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Adenylate cyclase (AC) toxin from Bordetefla pertuss& enters cells to cause supraphysiologic in reases in cAMP, AC toxin is also hemolytic. 
Substitution of Lys-SB with a methionine residue by site-directed mutagenesis of the structural gene for AC toxin, o'aA, and introduction of this 
mutation onto the B, pertussis chromosome r sults in an organism that synthesizes an enzyme-deficient AC toxin molecule, This mutant oxin 
molecule xhibits 1000-fold reduction in enzymatic activity relative to wild-tylX and has no toxin activity in J774 cells, The enzyme-deficient to, in 
molecule is not, however, impaired in its ability to lyse sheep red blood cells, in order to ascertain the importan~ of these two separate activities 
of AC toxin in vivo the enzyme-deficient organisms were used to infect infant mice. The hemob, tic, enzyme-deficient m mum organisms arc reduced 
in virulence relative to wild-type organisms after intranasal challenge indicating that, although the enzymatic activity of AC toxin does not contribute 
to hemolysis, it is this property of the toxin which is impor:ant for virulence of B, pertussis. 
Bordetella pertussis virulence; Hemolysis 
i. INTRODUCTION 
Bordetella pertussis is the causative agent of whoop- 
ing cough. Among the virulence factors elaborated by 
this organism isan adenylate eyclase (AC) toxin [1]. The 
AC toxin, which has an apparent tool. wt. of 216 kDa, 
enters eukaryotic ells and produces cAMP from en- 
dogenous ATP. Data from our laboratory and others 
demonstrate hat purified AC toxin is also a hemolysin 
[2-4]. 
The Bordetella denyla e cyclast~ toxin shares exten- 
sive homology with E. coli hemolysin [5], and both tox- 
ins are thought to be important virtdence factors in their 
respective hosts [1,6,7]. They produce osmotic lysis of 
red blood cells and are toxic to neutrophils. The E. coil 
hemolysin, however, possesses no associated enzymatic 
activity, and cell lysis which has immediate onset fol- 
lowing toxin addition is thought o be due to creation 
of transmembrane pores 18]. Although pore formation 
appems to play a role in the hemolytic activity of AC 
toxin [3,9] there is no evidence for that event in neutro- 
phils and monocytes where cellular dysfunction is attri- 
buted to target cell cAMP accumulation [10,11]. Fur- 
thermore, studies of the kinetics of intoxication and 
hemolysis by AC toxin reveal immediate onset of intra- 
cellular cAMP accumulation but a lag of 45-60 rain for 
detection of hemolysis [3]. These observations raise the 
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question ofwhether AC enzymatic activity may contrib- 
ute to or cause the hemolytic process by g¢neratio,a of 
cAMP, depletion of ATP or other unrecognized second- 
ary events. In order to address these issues an enzyme- 
deficient AC toxin mutant has been constructed and 
evaluated. 
2. MATER.IALS AND METHODS 
2.1. Bacterial .straim" and growth ~'onditions 
E. coil strains were maintained at -20~C as glycerol stocks, and 
grown on glucose minimal medium plates and in liquid LB medium. 
Strzins MM294 (pRK2013J and HBI01 (pSS1129) were used for con- 
jugation, MM294 (pRK20!3) was grown on L-agar with 50/J',dml 
kanamycin, and HBI01 (pSS1129) was grown on L-agar with 10/ag/ml 
gentamycin and 50/ag/ml ampicilllin, B. perlnssi~ strain SM00I (strep- 
tomycin-resistant derivative of BP338) was the recipient bacteria for 
conjugation. SM001 was grown on Bordet Oengoa (BG) plates or in 
Stainer-Seholte iquid medium supplemented with 30 ~£dml nalidixic 
acid and ~00 ~ug/ml streptomycin, 
2.2, MutagenesL~ 
Site-directed mutagenesis was ixrformed as desrribed by Kunk¢l 
[I 2] using the M uta-gene M I3 in vitro M utagenesis Kit from Bio-Rad 
and the procedure of Au et al. [13], 
2.3. Conjugatio~z arm recombination 
Plasmid pSSI 129, a derivative of pRTPI, was constructed by Stibitz 
et al. [14] to facilitate the exchange of mutant B. perlussis DNA for 
wild-type DNA on the B, pertussi.s chromosome. Plasmid pSS1129, 
containing a fragment of mutant o'uA, was mobilized by conjugation 
of plasmid RK2013 into Bordetella SM001 as described previously by 
Barry et al. [I 5], After 6 h the mixture was transferred onto !~G plates 
containing 30 #g/ml nalidixic acid and l0/~g/ml gentamycin to select 
for colonies containing the plasmid integrated into the chromosome. 
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Bacteria from the first selection were then grown on DG plates with 
streptomycin and nalidixic acid to identify bacteria which had excised 
the plasmid from the chromosome, The nalidixic acidlstreplomycin- 
resistant colonies were then screcncd for loss of enzymatic acGvity as 
described in results. 
Restriction endonuclease digestions were performed according to 
the specifications of the manufacturers. Ligations were performed ;II 
16% overnight in total volumeof 10~1 including fragment, vector and 
T4 DNA ligase. Transformations were performed according to stand- 
ard protocols. 
Adcnylatc cyclase iox;tl was purified as described previously [l6]. 
Enzymatic aciivity was measured by conversion of [@P]ATP to 
p!P]cA MP as described previousI> [ 171. 
2.7. Adqvlurr cyckts~’ toxin ctcriviry iti twh7terl cc’ll~s 
Adenylnte cyclase toxin activity was determined as described previ- 
ously [ 171 by quantitation of intracellular oAMtJ in 3774 cells treated 
with preparations containing the toxin. 
Adenylate cyclase loxin activity was measured in sheep erythrocytes 
as described previously [3] using CAMP determination by automated 
radioimmunoassay [IS]. 
2.9. SDS-PrlGE ad Wesrrrtt blot 
Blectrophoresis of protein samples was performed according to 
Laemmli on I .5 mM-thick SDS-polyacrylumide gels 1191, transferred 
to nitrocellulose sheets and ilxabated with anti-AC toxin monoclonal 
antibody, 9D4 [16.17], using the method of Towbin et al. [20]. 
Elemoly& assays were performed using sheep erythrocytes 3  target 
cells and the method of Clerc et al. [2l] with minor modilications 
described previclusly [3]. 
Intra-nasal challenge and bacterial colonization studies were both 
performed on 6.day-old infant mice as described previously [?a] using 
SMOOI and BPLMSBlE at the indicated inocula. To determine sur- 
vival of the bacteria in the lung, mice infected with 500colany forming 
units (cfu) were killed by methoxyflurane inhalation or cervical dislo- 
cation at 5-day intervals and the lungs were removed, Colony counts 
were determined by suspending the lungs in 5 ml of Stainer-Scholte 
broth, disrupting them for 60 s in a model 80 Stomacher laboratory 
blender, and plating dilutions on BG agar. Severity of infection was 
expressed as cfu of B. per~ussis per lung. 
2. RESULTS 
The AC toxin purified from Bo&tolirr pertussis is a 
single polypeptide with a mol. wt, of 177 kDa by calcu- 
lation from amino acid sequence [S] and by equilibrium 
sedimentation [24], but 200-216 kDa by SDS-PAGE 
[17,233. The discrepancy between these techniques i  felt 
to be due to incomplete denaturation under SDS- 
PAGE conditions [24]. We have described an accessory 
gene, c_~fiC, which CTXO&S a proSin hypothesized to
catalyze a post-translational modification required for 
toxin and hemolysin activities but not enzymatic activ- 
ity [IS]. In previous studies other investigators have 
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Fig. I. Schematic representation arc,@ indicalingfragmenls used for 
construction of enzyme-deficient muiants. 
isolated and examined mutants in the enzymatic portion 
of the adenylate cyclase [13,2S]. They employed mate- 
rial. however, from cloned genes expressed in E. coii 
which did not possess the cynC gene and therefore 
lacked toxin and hemolysin activities. To generate an 
active toxin and hemolysin we introduced the enzyme 
mutation into the Borhreilrr yerrussis chromosome and 
purified the protein from a strain that expressed all of 
the accessory genes. 
Construction of an enzyme-deficient AC toxin is 
based on studies by Au et al. [13] and Glaser et al. [25] 
who have identified two of the amino acids involved in 
ATP catalysis. In those studies site-directed mutagene- 
sis of Lys-58 to a glutamine or a methionine, or Lys-65 
to a glutamine, reduced the enzymatic activity of AC 
toxin by >500-fold. As the first step in producing a 
mutant holotoxin the 2,776 bp BrrntMI-EcoRI fragment 
(A. Fig. I) was cloned into M13mpl8, and site-directed 
mutagenesis was performed to substitute methionine for 
Lys-58, as described in section 2 and as previously de- 
scribed by Au et al. [13]. The advantage of these partic- 
ular base changes is that an NcoI restriction cndonu- 
clease site is created. Consequently the products of the 
mutagenesis reaction, as well as the B, pcrrussis organ- 
isms resulting from mating and allelic exchange, can be 
screened for the presence of the NcoI site. A representa- 
tive clone (M 13mpl8-LM58IE) with a new NC&site 
(NcoI*, Fig. 1) was identified and the presence of the 
predicted base changes was confirmed by Sanger dide- 
oxy sequencing (data not shown). 
The 994 base pair Ban1H1-Bcli fragment (B, Fig. 1) 
from MI3mpl8-LMSSIE was then cloned into the 
BmzHI site of the plasmid pSS1129 (described in Mate- 
rials and Methods). The mutation was introduced into 
8. pertussis by conjugation and homologous recombi- 
nation. One hundred of the resulting lransconjugants 
were screened for adenylate cyclase activity. When bac- 
terial suspensions of primary subcultures were tested, 
ten had no AC activity but they were hemolytic on 
blood agar plates, Southern blot analysis was per- 
formed using chromosomal DNA from two of the en- 
zyme-deficient coionies as well as a wild-type strain, 
confirming that the enzyme-deficient bacteria contain 
the newly created NcoI site while wild-type organisms 
do not (data not shown). 
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Once the position of the mutation in qu4 had been 
verified AC toxin was purified for functional studies 
from the resultant strain, BPLM581E, as described in 
section 2. The residual enzymatic activity of the mutant 
toxin is activated by calmodulin, indicating that the 
calmodulin-binding site has not been disturbed and en- 
abling the mutant protein to be purified by calmodulin- 
Sepharose chromatography. Calmodulin afhnity-puri- 
fied AC toxin from the wild-type parent and 
BPLMSSIE organisms were visualized by Coomassie 
staining after SDS-PAGE. As seen in Fig. 2A, the prep- 
arations appear identical. The 216 kDa band from each 
organism reacts on Western blot with anti-AC toxin 
monoclonal antibody 9D4, indicating that they repre- 
sent the purified holotoxin molecules (Fig. 2B). The 
degradation products observed only on Western blot 
reflect minor differences which are not explained. Char- 
acterization of the enzyme and toxin activities of AC 
toxin from SMOOI and BPLMWE demonstrates that 
the enzyme specific activity of BPLMSSIE AC toxin is 
reduced 1 OOO-fold relative to wild-type (wild-type 
SMOOI , 488 + 5 I pmol CAMP formedlminlmg in the 
presence of 1 AM calmodulin vs. BPLMSSlE, 0.412 + 
0.2). Furthermore AC toxin from BPLMSBIE has no 
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Fig. 2. AC toxin was purifed from BPLME5SIE and SMOOl as de- 
scribed 1171 previously. Calmodulin-Scpharose-purified AC toxins 
from the two strains (2.8 irg) were separated by 7.5% SDS-poly- 
acrylamidc gels. The gels were stained with Coomassie blue (A) or 
elcctroblottcd onto PVDF and probed with the monoclonal antibody. 
9D4 (B). Lanes A contain toxin from SMOO I and lanes B contain toxin 
Fig. 3. Time-course of hemolysis and cyclic AMP accumulation elic- 
ited by AC toxins from SMOOI and BPLMSSIE. (A) Calmod&t- 
Sepharose-purified AC toxin (75 ,udml) from SMOOI (e) or 
BPLME58I E (A) was incubated with 2 x lOR erythrocytes at 37°C and 
hemolysis was calculated at each point as described in section 2. (B) 
Aliquots of the same preparations from SMOOl (0) and BPLMSUE 
(A) were incubated with 3 x IO” erythrocytcs, and CAMP lcvcls were 
determined as described in section 2. B. prrrussis adcnylate cyclasc 
toxin activity represenrs the sum 0~intracellularcAMP and exrrxcilu- 
lar CAMP (from Ihe supernalilnt orlysed cells) at each time point. An 
asterisk indicates the basal value for CAMP (2.8 pmoV2 x IO” sheep 
!kom BPLMSSIE. erythrccytes 81 time 0). 
detectable toxin activity in 1774 cells, which are very 
sensitive to wild-type AC toxin (SMOOl, 10, 150 f 3300 
pmol cAMP/mg 5774 cells protein vs. BPLMSSIE, 15.2 
f 1.2 with basal CAMP in untreated cells 13.9 k 0.8). 
To determine if enzymatic activity and resultant 
CAMP production are essential for hemolysis, the timc- 
courses of lysis of red cells treated with wild-type or 
mutant toxin were compared. The data in Fig. 3 dcmon- 
strate that the AC toxin from BPLMS8IE is as hemo- 
lytic as wild-type toxin (A) yet does not elicit CAMP 
increases in erythrocytes (B). Since the onset of hemoly- 
sis with wild-type toxin is not more rapid than wi;h 
BPLM58IE and the rates are equivalent it appears that 
the presence of the enzymatic activity does not contrib- 
ute to hemolysis. These results demonstrate directly that 
adenylate cyclase enzymatic activity is not required for 
the hemolytic activity of AC toxin. 
In order to determine whether AC enzymatic activity 
is required for virulence of the intact organism we tested 
BPLM58IE for lethality in the infant mouse model 
which has been used previously for evaluation of B. 
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Fig. 4. Mortality ol’suckling mice as a function of bacterial inoculum. 
SMOOl (0. s) and BPLM58IE (1 A> were prepared as described and 
used for intranasal inoculation of suckling mice. Closed symbols rc- 
present mice that died by 28 days; open symbols indicate survivors. 
p~~~tssis v rulence factors [7,X]. Six-day-old Balb/cByJ 
mice were challenged intranasally with the indicated 
quantities of B. petmssb organisms (Fig, 4). At a dose 
of 5 x 10J wild-type organisms, 6/6 of the mice died. A 
20-fold higher dose of enzyme-deficient organisms (1 x 
13” cfu), however, killed only 3/7 of the mice. To elicit 
100% mortality mutant organisms (BPLM58IE) at a 
dose of 3.5 x 10’ cfu were required. These data demon- 
strate that the enzyme-deficient mutant is less virulent 
than wild-type B. prrtussis and comparable to BP238, 
a mutant which is totally lacking adenylate cyclase toxin 
protein, as described in previous studies [7]. 
The ability of the bacteria to persist in infant mice 
was also examined. When mice were inoculated with 
500 cfu, wild-type organisms multiplied within the lung 
and reached a maximal colony count of > 1 O6 organisms 
on day 1 S. The magnitude of infection with BPLMSSIE 
is several logs lower in cfu yet both organisms were 
cleared by 25-30 days after inoculation (Fig. 5). These 
data suggest hat adenylate cyclase enzymatic activity 
is important but not essential for colonization in the 
mouse lung, ils well as establishment of lethal infection 
when mice are challenged with BorderelCa organisms. 
4. DISCUSSION 
The kinetic studies comparing AC toxin-mediated he- 
molysis with intoxication [3,4] suggested that hemolysis 
might be a consequence of the enzymatic activity of the 
toxin because high levels of CAMP accumulate in the 
cell before lysis occurs. Under those circumstances 
adenylate cyclase toxin activity might cause or contrib- 
ute to hemolysis through ATP depletion and/or CAMP 
accumulation. Two observations indicated that CAMP 
0 I 
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Fig. 5. Lung bacterial colony counts at five-day intervals during infec- 
tion with SMUOI (0) or BPLMSHE (A). Suckling mice were chal- 
lengcd intradasally with 50 organisms on day 0 and groups sacrificed 
at S-day intervals. Quantitation of infection was carried out as dc- 
scribed in section 2 :md expressed as mean logcfu/lung ? S.E.M. Limil 
of dcteclion of Ihe assay was 500 organisms, indicated by a hat&cd 
line. With the exception or the 36day point for SMOOI (3 mice surviv- 
ing to sacrifice) all points represent mean values from 3-6 animals. 
accumulation is probably not the cause of hemolysis: (i) 
exposure of stored cells to AC toxin results in lower 
CAMP levels and more hemolysis than in freshly drawn 
red cells (Ehrmann et al. unpublished ata); (ii) addition 
of S-bromo-CAMP does not cause hemolysis 121. Conse- 
quently it was postulated that perhaps AC enzymatic 
activity contributed to hemolysis through ATP deple- 
tion, Construction of an enzyme-deficient AC toxin 
molecule has resolved the issue of whether enzymatic 
activity is responsible for hemolysis with resultant data 
demonstrating equivalent rates and magnitudes of he- 
molysis between wild-type and enzyme-deficient AC 
toxin. 
Since enzymatic activity does not cause AC toxin- 
mediated hemolysis. what is the clechanism of this lytic 
event? Data from osmotic protection experiments ug- 
gest hat AC toxin forms a pore in the erythrocyte mem- 
brane [3,9]. AC toxin interacts with target membranes 
within seconds [3,26] yet there is no evidence to indicate 
that a functional pore forms immediately because he- 
molysis does pr)t begin until at least 45 min later. It may 
be that pore formation is the rate limiting step for hemo- 
lysis. Two possible explanations for this delay in hemo- 
lysis are: (i) aggregation or oligomerization of the toxin 
is required for development of a functional pore; or (ii) 
that the toxin must be processed in the membrane bc- 
fore a pore is formed. If proteolysis of the toxin results 
in ‘opening’ of the pore and subsequent hemolysis, one 
might find lower molecular weight forms of AC toxin 
in the red cell membranes. Rogel et al. [4] however, have 
used SDS-PAGE to examine red cell membranes ex- 
posed to iodinated AC toxin and found only the high 
molecular weight form (216 kDa) of the toxin. It is still 
possible that proteolysis is occurring and that SDS- 
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PAGE may not be sufficiently sensitive to detect small 
changes in molecular weight of large proteins. Another 
explanation is that aggregation of the toxin is required 
for hemolysis. There is no experimental evidence to sup- 
port this hypothesis at present but the possibility is 
being explored with electron microscopy and more de- 
tailed kinetic studies. Nevertheless it appears that some 
processing step, which does not require AC enzymatic 
activity, occurs after AC toxin interacts with the red cell 
membrane and before hemolysis occurs. 
Not only is AC toxin which has been purified from 
the enzyme-deficient mutant useful as a reagent o ex- 
plore the role of enzymatic activity in hemolysis, it is 
also essential for determination of the role of AC activ- 
ity in vivo. The results from the lethal challenge of 
infant mice show that the enzyme-deficient mutant is 
less viru!ent than wild-type. The mutant BPLMSSIE, 
which synthesizes the enzyme-deficient toxin bul retains 
hcmolysin activity, is comparable in virulence to BP348 
[7], a mutant which produces no detectable AC toxin 
molecule. These two organisms exhibit similar LDSO val- 
ues, suggesting that the enzymatic activity and not the 
hemolytic activity is important in this test of virulence. 
Another organism, BPDE386, a c~‘aC gene mutant 
which is non-hemolytic but has full enzymatic activity, 
has also been shown to be less virulent than wild-type 
organisms for infant mice [15]. The gene product of 
cyaC is postulated to catalyze a post-translational mod- 
ification of the toxin rendering it capable of interacting 
with target cells, The results of these studies uggest hat 
full virulence of B. pertussis organisms is dependent 
upon possession of an AC toxin with enzymatic activity 
and the ability to interact with target cell membranes. 
In addition to determination of doses required for 
lethal infection the bacteria were tested for their ability 
to survive in the mouse lung. Both wild-type and 
BPLM58IE were cleared by 25-30 days. Colony counts 
in the lungs, however, were higher in the mice infected 
with the wild-type strain. These results suggest hat AC 
enzymatic activity may affect the magnitude but not the 
duration of infection, and are consistent with the in 
vitro studies which suggested that the AC enzymatic 
activity helps the organism evade immune effector cells 
by interfering with bacterial kiKng mechanisms such as 
superoxide production [lO,ll]. 
In contrast to S coli hemolysin, which appears to be 
a virulence factor as a consequence of its hemolytic 
activity [6,8], it appears that AC enzymatic activity, 
more than henolytic activity, is important in vivo. Since 
E. cd hcmolysin and AC toxin share sequence homol- 
ogy and some structural similarity [3,5,25] it was postu- 
lated that the mechanisms of hemolysis and virulence 
might be the same. Although both toxins may form 
pores in red ceils i&5,5] E. cd hemolysin iySCS CC!!s 
immediately while AC toxin displays a lag period. it was 
believed that a contribution of AC enzymatic activity to 
hemolysis might provide an explanation for the differ- 
ence in kinetics of hemolysis between the two toxins, yet 
it now appears that AC enzymatic activity has no role 
in hemolysis. Whether there is any strustural role for the 
N-terminal catalytic domain (even when inactive) in 
hemolysis remains to be determined. Thus, it is reason- 
able to conclude that the hemolytic activity of the AC 
toxin contributes little or nothing to the virulence of B. 
perrussis in the absence of enzymatic activity. Further 
study of the mechanism of AC toxin-mediated hemoly- 
sis will surely enhance our understanding of the way in 
which AC toxin and other bacterial toxins interact with 
target cell membranes. 
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